Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Osteoporosis

Romosozumab reduces fracture risk in postmenopausal women with osteoporosis

Researchers find that the drug can be an effective treatment for women who are susceptible to fracture.

Scanning electron micrograph of osteoporotic bone

Source: Prof P Motta / Science Photo Library

Researchers investigated the effect of romosozumab, a monoclonal antibody, on the risk of fracture in a randomised controlled trial of 7,180 postmenopausal women with osteoporosis aged 55–85 years old

Around 40% of women with postmenopausal osteoporosis will go on to sustain one or more fragility fractures.

Researchers investigated the effect of romosozumab, a monoclonal antibody, in a randomised controlled trial of 7,180 postmenopausal women aged 55–85 years old. All participants had abnormally low bone mineral density scores in their spine, hip and femoral neck and were assigned to either a monthly dose of romosozumab, or placebo.

After one year it was found that romosozumab was associated with an 83% lower risk of clinical vertebral fracture at 12 months, compared with placebo. The effect of the drug on the risk of vertebral fracture was found to be rapid, with only two additional vertebral fractures, of a total of 16, occurring in the second 6 months of therapy.

Presenting at the Annual European Congress of Rheumatology (14 June 2017), the authors concluded that romosozumab could be used as an effective treatment for postmenopausal women with osteoporosis who are at increased risk of fracture[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203555

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.